LifeSci Acquisition II Corp. (LSAQ) Research

LifeSci Acquisition II Corp. aims to complete a business combination, such as a merger, share exchange, asset or stock acquisition, recapitalization, or reorganization, with one or more entities in the healthcare industry. Established in 2019, the company is headquartered in New York, New York.

Market snapshot

Symbol
LSAQ
Price
$9.01
Day change
-1.96%
Market cap
$1.1B
52-week range
8.4166-9.25
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Amplitude Healthcare Acquisition Corporation (AMHC)
  • Churchill Capital Corp VII (CVII)
  • FG New America Acquisition Corp. (FGNA)
  • Franklin Pennsylvania Municipal Income ETF (FTPA)
  • FTAC Hera Acquisition Corp. (HERA)
  • Humacyte, Inc. (HUMA)
  • TPG Pace Tech Opportunities Corp. (PACE)
  • Therapeutics Acquisition Corp. (RACA)

Recent insider activity

  • McDonald Andrew I — J-Other (138591 shares) on 2021-08-25
  • Rice Michael Yehuda — J-Other (138591 shares) on 2021-08-25
  • Rice Michael Yehuda — A-Award (3146453 shares) on 2020-11-24
  • McDonald Andrew I — A-Award (3146453 shares) on 2020-11-24
  • Janssen Scott — trade (0 shares) on 2020-11-20

Open LifeSci Acquisition II Corp. (LSAQ) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.